A holistic approach to predicting diabetes risk via biomarkers

Leo Tolstoy's novel Anna Karenina starts with the famous line, “All happy families are alike; each unhappy family is unhappy in its own way.” This “Anna Karenina Principle” has been applied in numerous contexts, including ecological risk assessment, microbiomes, economics, and many others. In physiology and health, we might rephrase it as a hypothesis; “All healthy physiologies are healthy in relatively standard ways, but there are limitless ways in which physiology can go awry.” This hypothesis raises interesting corollaries: to what extent is there a general, unique profile of physiological “health,” which might be perturbed in a multiplicity of ways? Can we understand health as the body's ability to maintain such a homeostatic state, or more broadly its dynamic equilibrium? Might having an overall profile that is far from average be an indicator either of a specific but undiagnosed pathology, or of a general lack of resiliency predisposing the individual to higher risks of a host of adverse outcomes? One way to operationalize the Anna Karenina Principle and tackle such questions is via the Mahalanobis distance (MD), a measure that assesses how unusual a multivariate profile is, taking into account known correlations among the variables [[1]Mahalanobis PC. Mahalanobis distance.Proc Natl Inst Sci India. 1936; 49: 234-256Google Scholar]. In the health context, it can be applied to standard clinical biomarkers [[2]Cohen AA Milot E Yong J Seplaki CL Fülöp T Bandeen-Roche K et al.A novel statistical approach shows evidence for multi-system physiological dysregulation during aging.Mech Ageing Dev. 2013; 134https://doi.org/10.1016/j.mad.2013.01.004Crossref PubMed Scopus (76) Google Scholar]. High MD scores (i.e., more unusual profiles) were hypothesized to represent homeostatic dysregulation, and have since been shown to increase with age and predict numerous adverse health outcomes, as well as to be associated with diet and socioeconomic predictors of health [[3]Belsky DW Huffman KM Pieper CF Shalev I Kraus WE. Change in the rate of biological aging in response to caloric restriction: CALERIE biobank analysis.J Gerontol A Biol Sci Med Sci. 2017; 73: 4-10Crossref PubMed Scopus (69) Google Scholar,[4]Milot E Morissette-Thomas V Li Q Fried LP Ferrucci L Cohen AA. Trajectories of physiological dysregulation predicts mortality and health outcomes in a consistent manner across three populations.Mech Ageing Dev. 2014; : 141-142https://doi.org/10.1016/j.mad.2014.10.001Crossref Scopus (43) Google Scholar]. This approach has been used in both industrialized and non-industrialized human populations, as well as in various species [5Kraft T Stiegilitz J Trumble BC Garcia A Kaplan HS Gurven MD. Physiological dysregulation and aging in evolutionary perspective.Philos Trans R Soc Lond B Biol Sci n.d. 2019; Google Scholar, 6Shahrestani P Tran X Mueller LD. Physiology declines prior to death in Drosophila melanogaster.Biogerontology. 2012; https://doi.org/10.1007/s10522-012-9398-zCrossref PubMed Scopus (7) Google Scholar, 7Dansereau G Wey TW Legault V Brunet MA Kemnitz JW Ferrucci L et al.Conservation of physiological dysregulation signatures of aging across primates.Aging Cell. 2019; 18https://doi.org/10.1111/acel.12925Crossref PubMed Scopus (13) Google Scholar]. Counterintuitively, this approach can generate information that is not available by examining the component biomarkers one at a time – for example, individuals who have clinically normal profiles on every individual biomarker can still have overall profiles that are highly aberrant and suggest high health risk. In this issue of EBioMedicine, Flores-Guerrero et al. [[8]Flores-Guerrero JL Grzegorczyk MA Connelly MA Garcia E Navis G Dullaart RPF et al.Mahalanobis distance, a novel statistical proxy of homeostasis loss is longitudinally associated with risk of type 2 diabetes.EBioMedicine. 2021; 71103550Summary Full Text Full Text PDF PubMed Scopus (1) Google Scholar] break new ground by bringing the MD metric toward the clinical realm. Specifically, using a longitudinal sample of 6,247 non-diabetics in the Netherlands, they asked whether MD scores calculated from 32 circulating biomarkers predicted risk of Type-II diabetes incidence. Across an elegant series of analyses, they consistently found support for this hypothesis. Furthermore, MD appears to be at least partially tapping into information that is not generally included in current diabetes prediction: hazard ratios remained important after adjustment for classical risk factors such as glucose level, obesity, and family history. The non-negligible effect sizes suggest substantial potential to integrate the information into clinical risk algorithms, though much work would remain to identify an optimal biomarker panel, demonstrate superiority to existing algorithms, and validate clinical utility. Etiologically, some of the sensitivity analyses presented by Flores-Guerrero et al. [[8]Flores-Guerrero JL Grzegorczyk MA Connelly MA Garcia E Navis G Dullaart RPF et al.Mahalanobis distance, a novel statistical proxy of homeostasis loss is longitudinally associated with risk of type 2 diabetes.EBioMedicine. 2021; 71103550Summary Full Text Full Text PDF PubMed Scopus (1) Google Scholar] imply that the MD signal is broadly distributed among many biomarkers rather than specific to a set of cardio-metabolic indicators, making it unlikely that MD is directly detecting metabolic syndrome or related diabetes precursors. Rather, MD may detect a more general physiological dysfunction that can feed into metabolic processes, or an incidental correlate such as a lifestyle-driven dysfunction that could co-vary with diabetes risk. Teasing apart such hypotheses will be important to validate the clinical potential. Going forward, the work by Flores-Guerrero et al. [[8]Flores-Guerrero JL Grzegorczyk MA Connelly MA Garcia E Navis G Dullaart RPF et al.Mahalanobis distance, a novel statistical proxy of homeostasis loss is longitudinally associated with risk of type 2 diabetes.EBioMedicine. 2021; 71103550Summary Full Text Full Text PDF PubMed Scopus (1) Google Scholar] is likely to represent the tip of the iceberg, both in terms of clinically oriented applications of MD, and for development of multivariate approaches to synthesize relevant underlying physiological processes. More broadly, the Anna Karenina Principle is one expression of a more general shift toward network physiology, network medicine, and complexity science in biomedicine [[9]Ivanov PC Liu KKL Bartsch RP. Focus on the emerging new fields of network physiology and network medicine.New J Phys. 2016; 18https://doi.org/10.1088/1367-2630/18/10/100201Crossref PubMed Scopus (117) Google Scholar]. The underlying model of physiology supposed by the approach is a gentle challenge to the reductionist approaches that tend to dominate biomedical research. Reductionism breaks the biology down into component molecules, cells, and pathways, and looks for highly specific diagnostic or therapeutic molecules. This conventional approach has certainly produced some impressive results, and will continue to do so, but in many domains reductionism has already picked the lowest hanging fruits, and is bumping up against the limits of small effect sizes, contingent results and complex networks of molecules that defy simple characterization or manipulation. For example, Alzheimer's research targeting amyloid-beta has been strikingly unsuccessful, perhaps due to a failure to understand the complexity of amyloid-beta's integration into immune networks and the delicate balance between adaptation and pathology [[10]Fulop T Witkowski JM Bourgade K Khalil A Zerif E Larbi A et al.Can an infection hypothesis explain the beta amyloid hypothesis of Alzheimer's disease?.Front Aging Neurosci. 2018; 10: 224Crossref PubMed Scopus (75) Google Scholar]. The broader question posed by Flores-Guerrero et al. [[8]Flores-Guerrero JL Grzegorczyk MA Connelly MA Garcia E Navis G Dullaart RPF et al.Mahalanobis distance, a novel statistical proxy of homeostasis loss is longitudinally associated with risk of type 2 diabetes.EBioMedicine. 2021; 71103550Summary Full Text Full Text PDF PubMed Scopus (1) Google Scholar] is, what might we gain by using integrative rather than compartmentalized ways to study physiology? In both clinical and research contexts, methods such as MD present a way to reconceptualize health in a more integrative fashion and to uncover novel processes that function at the intersection of multiple pathways and systems. Long-term, this will fuel more precise and personalized interventions that account for the ensemble of an individual's dynamic physiology. AAC is the sole author. AAC is founder and CEO at Oken Health. Mahalanobis distance, a novel statistical proxy of homeostasis loss is longitudinally associated with risk of type 2 diabetesOur results are in line with the premise that MD represents an estimate of homeostasis loss. This study suggests that MD is able to provide information about physiological dysregulation also in the pathogenesis of T2D. Full-Text PDF Open Access

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.